Drugs / Luminenz-AT
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00881452 Comparator | May 2009 → Jun 2011 | autism | Curemark | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Luminenz-AT | “CM-AT (Luminenz-AT)- 900mg CM-AT, pancreatic enzyme concentrate (720mg)” NCT00881452 ↗ |
| Known as | CM-AT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00881452 ↗ |
| Modality | Protein / enzyme biologic | “CM-AT is a proprietary enzyme” NCT00881452 ↗ |